Rigel Pharmaceuticals (RIGL) Return on Equity [ROE] (2011 - 2026)
Rigel Pharmaceuticals (RIGL) posted Return on Equity [ROE] of 78.01% for Q2 2026, down 116.66 percentage points from 194.67% a year earlier and down 14.04 percentage points from the prior quarter.
Powered by 
Analysis
Rigel Pharmaceuticals (RIGL) Return on Equity [ROE] (2011 - 2026) Analysis & Trends
For FY2025, Rigel Pharmaceuticals' Return on Equity [ROE] came in at 185.94%.
- Annual Return on Equity [ROE] shows a five-year change of +253.67 percentage points (FY2020 to FY2025).
- In prior years, Rigel Pharmaceuticals' Return on Equity [ROE] was -699.05% in FY2022 (-643.41 pp) and -55.63% in FY2021 (+12.09 pp).
- The Q2 2026 figure stands as the lowest quarterly Return on Equity [ROE] since Q2 2022.
- According to Business Quant data, Return on Equity [ROE] for the three prior quarters was 92.05% (Q1 2026), 144.19% (Q4 2025) and 113.56% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 82.09% |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 25.32% |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | - |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 7.21% |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 84.40% |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 21.39% |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 83.75% |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -18.38% |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 4.97% |
| 10 | Rigel Pharmaceuticals | 880.76 Mn | 346.64 Mn | 70.18 Mn | 78.01% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 78.01% |
| Mar 31, 2026 | 92.05% |
| Dec 31, 2025 | 144.19% |
| Sep 30, 2025 | 113.56% |
| Jun 30, 2025 | 194.67% |
| Mar 31, 2025 | 340.22% |
| Jun 30, 2022 | -5,414.61% |
| Mar 31, 2022 | -456.23% |
| Dec 31, 2021 | -44.67% |
| Sep 30, 2021 | -24.64% |
| Jun 30, 2021 | -10.56% |
| Mar 31, 2021 | -20.50% |
| Dec 31, 2020 | -70.00% |
| Sep 30, 2020 | -48.54% |
| Jun 30, 2020 | -35.32% |
| Mar 31, 2020 | -42.40% |
| Dec 31, 2019 | -109.01% |
| Sep 30, 2019 | -63.13% |
| Jun 30, 2019 | -67.67% |
| Mar 31, 2019 | -62.08% |
API Access
Rigel Pharmaceuticals Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=RIGL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "RIGL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=RIGL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();